Holen Sie sich die Stockscreener-App
0.91
1.54%
-0.0143
Schlusskurs vom Vortag:
$0.9243
Offen:
$0.92
24-Stunden-Volumen:
154.21K
Relative Volume:
0.51
Marktkapitalisierung:
$5.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.47M
KGV:
-0.0958
EPS:
-9.5
Netto-Cashflow:
$-24.56M
1W Leistung:
-14.15%
1M Leistung:
-37.24%
6M Leistung:
-71.11%
1J Leistung:
-87.68%
1-Tages-Spanne:
$0.8703
$0.938
1-Wochen-Bereich:
$0.83
$0.99
52-Wochen-Spanne:
$0.83
$13.61
Evaxion Biotech A S Adr Stock (EVAX) Company Profile
Firmenname
Evaxion Biotech A S Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVAX
Evaxion Biotech A S Adr
|
0.91 | 5.34M | 0 | -24.47M | -24.56M | -9.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.11 | 104.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.15 | 78.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
621.29 | 37.15B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.28 | 30.22B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.79 | 27.76B | 3.30B | -501.07M | 1.03B | -2.1146 |
Evaxion Biotech A S Adr Stock (EVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-02 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Eingeleitet | H.C. Wainwright | Buy |
Evaxion Biotech A S Adr Aktie (EVAX) Neueste Nachrichten
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN
European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading - MSN
US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About Santa Rally - Benzinga
Evaxion Biotech stock hits 52-week low at $0.84 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Fall in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.92 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week - MSN
European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN
Evaxion achieves preclinical success with AI cancer vaccine - Investing.com
Evaxion Biotech stock hits 52-week low at $1.19 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $1.31 By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $1.31 - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
Evaxion appeals Nasdaq delisting determination - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week - MSN
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - MSN
Evaxion Biotech Reports Q3 Progress and Financials - TipRanks
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Friday - MSN
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN
Evaxion reports improved AI vaccine target predictions - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle
EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Finanzdaten der Evaxion Biotech A S Adr-Aktie (EVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):